bone marrow ['bəun ,mærəu]

bone marrow的基本解释

n.

骨髓

bone marrow的同义词

n. marrow

与bone marrow相关的网络例句 [注：此内容来源于网络，仅供参考]

Results In those patients with marrow invasion , 4 cases in I phase（4.2%）,12 cases in II phase（12.6%）,36 cases in Ⅲ phase（37.9%）and 43 cases in Ⅳ phase(47.4%);small lymphocytic、diffuse cleaved cell、lymphoblastic lymphoma are main pathologic types;patients with mediastinal lymphadenectasis、splenomegaly and spleen violations are prone to catch bone marrow involvement;56 cases of anemia in patients with bone marrow involuement(58.9%), 42 patients with thrombocytopenia (44.2%),27 cases with leukopenia (28.4%),49 cases of patients leukocyte increased (51.6%),so,anemia is common;three were 30 cases with three items abnormal（31.6％）and 65 cases with one item abnormal at least (68.4%),the incidence of abnormal peripheral blood in leukocythemia patients were higher than that in patients with bone marrow infiltration,Particularly the patients with increased leukocyte or three items abnormalities were more common in leukemia; Abnormal cells in peripheral blood were observed in 66 cases (69.5%); chemotherapy efficiency reached 65.2% in the patients with bone marrow involuement,the median survival time was 11.5 months.

结果发生骨髓侵犯病例中I期4例（4.2%）， II期12例（12.6%），Ⅲ期36例（37.9%），Ⅳ期43例(47.4%)；病理类型以小淋巴细胞性，弥漫型裂细胞性（改为：弥漫性大B细胞型淋巴瘤）和淋巴母细胞性淋巴瘤多见；纵隔淋巴结肿大、脾脏肿大和脾受侵患者易发生骨髓侵犯；骨髓侵犯患者外周血中贫血56例(58.9%)，血小板减少42例(44.2%)，白细胞减少27例(28.4%)，白细胞增高49例(51.6%)，以贫血多见；三项均异常30例(31.6%)，至少一项不正常65例(68.4%)，淋巴瘤细胞白血病患者外周血象异常发生率高于骨髓浸润患者，尤其是白细胞增高或三项均异常者更常见于白血病；66例(69.5%)外周血分类中发现异常细胞；骨髓侵犯化疗有效率65.2%，中位生存期11.5个月。

Results In those patients with marrow invasion , 4 cases in I phase（4.2%）,12 cases in II phase（12.6%）,36 cases in Ⅲ phase（37.9%）and 43 cases in Ⅳ phase(47.4%);small lymphocytic、diffuse cleaved cell、lymphoblastic lymphoma are main pathologic types;patients with mediastinal lymphadenectasis、splenomegaly and spleen violations are prone to catch bone marrow involvement;56 cases of anemia in patients with bone marrow involuement(58.9%)恶性淋巴瘤症状, 42 patients with thrombocytopenia (44.2%),27 cases with leukopenia (28.4%),49 cases of patients leukocyte increased (51.6%),so,anemia is common;three were 30 cases with three items abnormal（31.6％）and 65 cases with one item abnormal at least (68.4%),the incidence of abnormal peripheral blood in leukocythemia patients were higher than that in patients with bone marrow infiltration,Particularly the patients with increased leukocyte or three items abnormalities were more common in leukemia; Abnormal cells in peripheral blood were observed in 66 cases (69.5%); chemotherapy efficiency reached 65.2% in the patients with bone marrow involuement,the median survival time was 11.5 months.

结果发生骨髓侵犯病例中I期4例（4.2%）， II期12例（12.6%），Ⅲ期36例（37.9%）恶性淋巴瘤分期，Ⅳ期43例(47.4%)；病理类型以小淋巴细胞性，弥漫型裂细胞性（改为：弥漫性大B细胞型淋巴瘤）和淋巴母细胞性淋巴瘤多见；纵隔淋巴结肿大、脾脏肿大和脾受侵患者易发生骨髓侵犯；骨髓侵犯患者外周血中贫血56例(58.9%)，血小板减少42例(44.2%)，白细胞减少27例(28.4%)，白细胞增高49例(51.6%)，以贫血多见；三项均异常30例(31.6%)，至少一项不正常65例(68.4%)，淋巴瘤细胞白血病患者外周血象异常发生率高于骨髓浸润患者，尤其是白细胞增高或三项均异常者更常见于白血病；66例(69.5%)外周血分类中发现异常细胞；骨髓侵犯化疗有效率65.2%，中位生存期11.5个月。

In the second part of this thesis. The biological process of porons HA/bBMP composite repairing experimental defect in the dog femora and monkey mandibular were investigated by the qualitative and quantitative methods. The results showed that not only were the speed and time of new bone ingrowing into the bBMP/HA composite much quicker and earlier than that of implants of HA alone, but also the quantity of new bone ingrowth into bBMP/HA composite was much higher than that of HA alone. The bone ingrowth of bBMP/HA composite at higher rate within 3 weeks. In this study, bBMP/HA promoted more active new bone formation in bone marrow tissue than did HA alone. This reveals that BMP, brought into the bone marrow with HA as a carrier, accelerates osteogenesis or osteoinduction, providing sime bone marrow cells with more differentiative potential.

论文第二部分应用定性和定量的方法，较全面地研究了HA/bBMP复合人工骨在修复狗股骨和猴下颌骨实验性缺损中的生物学过程，研究发现，新骨组织长入HA/bBMP复合人工骨的时间和速度都较单纯HA早和快，而且新骨形成量也明显高于单纯HA，HA/bBMP在挂入后早期(3周)的成骨最为活跃，自体骨髓组织可为BMP提供敏感的靶细胞，增强BMP的骨诱导效果和HA/bBMP复合人工骨的骨修复能力。

与bone marrow相关的网络解释 [注：此内容来源于网络，仅供参考]

bone marrow：骨髓

(一) 免疫器官1、中枢免疫器官1) 骨髓(Bone marrow)样组织:鱼类无淋巴造血的骨髓,但在软骨鱼的眶区和颅下区存在淋巴组织或骨髓样组织,可形成血细胞,具有与高等脊椎动物骨髓相似的结构与功能.

bone marrow：髓

大家都知道,骨髓(bone marrow)是产生细胞的地方,最初产生的细胞叫干细胞(stem cells),骨髓干细胞促使生成组成血液的原细胞(progenitor cells),原细胞最后发展为红血细胞和白血细胞(具免疫功能).

bone marrow：照射

胎肝:bone marrow | 照射:Bone marrow | 骨髓:bone marrow

bone marrow：胎肝

骨髓间充质干细胞/骨髓基质细胞:bone marrow mesenchymal stem cell/ bone marrow stromal cell | 胎肝:bone marrow | 照射:Bone marrow

bone marrow：abbr. bm; 骨髓